| Adenomatous polyposis coli | APC |
| Azoxymethane/dextran sodium sulfate | AOM/ASS |
| B. fragilis toxin | BFT |
| Berberine | BBR |
| Calcineurin and cytoplasmic 3 | Nfatc3 |
| Capecitabine | CAP or XELODA or XEL |
| Capecitabine oxaliplatin | CAPeOX |
| Caspase | casp |
| Cluster of differentiation | CD |
| Colorectal cancer | CRC |
| Cyclooxygenase-2 | COX-2 |
| Cytotoxic T lymphocyte antigen 4 | CTLA-4 |
| Early-onset colorectal cancer | EOCRC |
| Enterotoxigenic B. fragilis | ETBF |
| Epidermal growth factor receptor | EGFR |
| Fecal microbiota transplantation | FMT |
| Fluorouracile | 5-FU |
| Fusobacterium nucleatum | Fn |
| Germ-free | GF |
| High fat diet | HFD |
| Interleukin | IL |
| Irinotecan | IRI |
| Janus kinase/signal transducer and activator of transcription | JAK/STAT |
| Ketogenic diet | KD |
| Mitogen-activated protein kinase/extracellular signal-regulated kinases | MAPK/ERK |
| Non-enterotoxigenic Bacteroides fragilis | NTBF |
| Nuclear factor kappa light chain enhancer of activated B cells | NF-κB |
| Oxaliplatin | OX |
| Programmed cell death protein | PD-1 |
| Short chain fatty acids | SCFAs |
| Transforming growth factor | TGF |
| Tumor microenvironment | TME |
| Tumor necrosis factor | TNF |
| Vascular endothelial growth factor | VEGF |